Sign up to save your podcasts
Or
Share 11.18.2024 - Extended Benefit
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
11.18.2024 - Extended Benefit
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Check out the website and subscribe to the newsletter!
www.quadshotnews.com
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
View all episodes
By Laura, Caleb, and Sam
4.9
6161 ratings
Check out this week's QuadCast as we highlight the oncologic benefit of extended nodal dissection for prostate cancer, the comparison of Durvalumab and Cetuximab in cisplatin-ineligible H&N cancer patients, the high incidence of psoriasis development on immunotherapy, and more.
Check out the website and subscribe to the newsletter!
www.quadshotnews.com
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
More shows like QuadShot News Podcast
View all
Planet Money
30,795 Listeners
Global News Podcast
7,709 Listeners
Marketplace
8,772 Listeners
60 Minutes
2,736 Listeners
White Coat Investor Podcast
2,441 Listeners
The Daily
112,401 Listeners
Up First from NPR
56,702 Listeners
Today, Explained
10,239 Listeners
ASCO Guidelines
45 Listeners
Cautionary Tales with Tim Harford
5,136 Listeners
Hard Fork
5,522 Listeners
Breaking Points with Krystal and Saagar
10,042 Listeners
At The Beam
38 Listeners
The NRG Oncology Podcast
10 Listeners
On Target
0 Listeners